DPP4, the Middle East Respiratory Syndrome Coronavirus Receptor, is Upregulated in Lungs of Smokers and Chronic Obstructive Pulmonary Disease Patients

Clinical Infectious Diseases

Volumn 66, Issue 1, 2018, Pages 45-53

  Seys, Leen J M ^a,b   Widagdo, W ^c   Verhamme, Fien M ^a   KleinJan, Alex ^d   Janssens, Wim ^e   Joos, Guy F ^a   Bracke, Ken R ^a   Haagmans, Bart L ^c   Brusselle, Guy G ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

^c Erasmus MC Department of Viroscience   (Netherlands)

^d Departments of Pulmonary Medicine   (Netherlands)

^e UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

chronic obstructive pulmonary disease (COPD).; dipeptidyl peptidase 4 (DPP4); Middle East respiratory syndrome coronavirus (MERS CoV); smoking

Indexed keywords

DIPEPTIDYL PEPTIDASE IV; MESSENGER RNA; DPP4 PROTEIN, HUMAN; VIRUS RECEPTOR;

ADULT; AGED; AIRFLOW; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG DIFFUSION CAPACITY; LUNG FUNCTION; LUNG PARENCHYMA; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; MIDDLE EAST RESPIRATORY SYNDROME; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOKING; UPREGULATION; ADVERSE EVENT; LUNG; MIDDLE AGED; PATHOLOGY; QUESTIONNAIRE;

ADULT; AGED; DIPEPTIDYL PEPTIDASE 4; FEMALE; HUMANS; LUNG; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECEPTORS, VIRUS; SMOKING; SURVEYS AND QUESTIONNAIRES; UP-REGULATION;

EID: 85040560766     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cix741     Document Type: Article

References (37)

1. Arabi YM, Balkhy HH, Hayden FG, et al. Middle East Respiratory Syndrome. N Engl J Med 2017; 376:584-94.
2. WHO. Disease outbreak news: Middle East respiratory syndrome coronavirus (MERS-CoV) per 4 April 2017. Global Alert and Response (GAR)-World Health Organization (WHO), 2017.
3. Min CK, Cheon S, Ha NY, et al. Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity. Sci Rep 2016; 6:25359.
4. Kim SW, Park JW, Jung HD, et al. Risk factors for transmission of Middle East respiratory syndrome coronavirus infection during the 2015 outbreak in South Korea. Clin Infect Dis 2017; 64:551-7.
5. Drosten C, Meyer B, M ler MA, et al. Transmission of MERS-coronavirus in household contacts. N Engl J Med 2014; 371:828-35.
6. Al-Gethamy M, Corman VM, Hussain R, Al-Tawfiq JA, Drosten C, Memish ZA. A case of long-term excretion and subclinical infection with Middle East respiratory syndrome coronavirus in a healthcare worker. Clin Infect Dis 2015; 60:973-4.
7. Saad M, Omrani AS, Baig K, et al. Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: A single-center experience in Saudi Arabia. Int J Infect Dis 2014; 29:301-6.
8. Raj VS, Mou H, Smits SL, et al. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature 2013; 495:251-4.
9. Boonacker E, Van Noorden CJ. The multifunctional or moonlighting protein CD26/DPPIV. Eur J Cell Biol 2003; 82:53-73.
10. Barreira da Silva R, Laird ME, Yatim N, Fiette L, Ingersoll MA, Albert ML. Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy. Nat Immunol 2015; 16:850-8.
11. Mortier A, Gouwy M, Van Damme J, Proost P, Struyf S. CD26/dipeptidylpeptidase IV-chemokine interactions: Double-edged regulation of inflammation and tumor biology. J Leukoc Biol 2016; 99:955-69.
12. Vanhoof G, De Meester I, van Sande M, Scharp S, Yaron A. Distribution of proline-specific aminopeptidases in human tissues and body fluids. Eur J Clin Chem Clin Biochem 1992; 30:333-8.
13. Meyerholz DK, Lambertz AM, McCray PB Jr. Dipeptidyl peptidase 4 distribution in the human respiratory tract: Implications for the Middle East respiratory syndrome. Am J Pathol 2016; 186:78-86.
14. Scheuplein VA, Seifried J, Malczyk AH, et al. High secretion of interferons by human plasmacytoid dendritic cells upon recognition of Middle East respiratory syndrome coronavirus. J Virol 2015; 89:3859-69.
15. Widagdo W, Raj VS, Schipper D, et al. Differential expression of the Middle East respiratory syndrome coronavirus receptor in the upper respiratory tracts of humans and dromedary camels. J Virol 2016; 90:4838-42.
16. Vliegen G, Raju TK, Adriaensen D, Lambeir AM, De Meester I. The expression of proline-specific enzymes in the human lung. Ann Transl Med 2017; 5:130.
17. de Wit E, Rasmussen AL, Falzarano D, et al. Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques. Proc Natl Acad Sci USA 2013; 110:16598-603.
18. Alraddadi BM, Watson JT, Almarashi A, et al. Risk factors for primary middle east respiratory syndrome coronavirus illness in humans, Saudi Arabia, 2014. Emerg Infect Dis 2016; 22:49-55.
19. Vestbo J, Hurd SS, Agust AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013; 187:347-65.
20. Brusselle GG, Joos GF, Bracke KR. New insights into the immunology of chronic obstructive pulmonary disease. Lancet 2011; 378:1015-26.
21. Verhoeven GT, Verbraak AF, Boere-van der Straat S, Hoogsteden HC, Bogaard JM. Influence of lung parenchymal destruction on the different indexes of the methacholine dose-response curve in COPD patients. Chest 2000; 117:984-90.
22. Tashkin DP, Altose MD, Bleecker ER, et al. The lung health study: Airway responsiveness to inhaled methacholine in smokers with mild to moderate airflow limitation. The Lung Health Study Research Group. Am Rev Respir Dis 1992; 145:301-10.
23. Braunstahl GJ, Fokkens WJ, Overbeek SE, KleinJan A, Hoogsteden HC, Prins JB. Mucosal and systemic inflammatory changes in allergic rhinitis and asthma: A comparison between upper and lower airways. Clin Exp Allergy 2003; 33:579-87.
24. Demedts IK, Brusselle GG, Vermaelen KY, Pauwels RA. Identification and characterization of human pulmonary dendritic cells. Am J Respir Cell Mol Biol 2005; 32:177-84.
25. Seys LJ, Verhamme FM, Schinwald A, et al. Role of B cell-activating factor in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2015; 192:706-18.
26. Vandesompele J, De Preter K, Pattyn F, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002; 3:RESEARCH0034.1-11.
27. Shi S, Kanasaki K, Koya D. Linagliptin but not sitagliptin inhibited transforming growth factor-2-induced endothelial DPP-4 activity and the endothelial-mesenchymal transition. Biochem Biophys Res Commun 2016; 471:184-90.
28. Brightling CE, Chanez P, Leigh R, et al. Efficacy and safety of tralokinumab in patients with severe uncontrolled asthma: A randomised, double-blind, placebo-controlled, phase 2b trial. Lancet Respir Med 2015; 3:692-701.
29. Verhamme FM, Bracke KR, Joos GF, Brusselle GG. Transforming growth factor-superfamily in obstructive lung diseases: More suspects than TGF-A lone. Am J Respir Cell Mol Biol 2015; 52:653-62.
30. Kim V, Rogers TJ, Criner GJ. New concepts in the pathobiology of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2008; 5:478-85.
31. Zhong J, Rao X, Rajagopalan S. An emerging role of dipeptidyl peptidase 4 (DPP4) beyond glucose control: Potential implications in cardiovascular disease. Atherosclerosis 2013; 226:305-14.
32. Pacheco R, Martinez-Navio JM, Lejeune M, et al. CD26, adenosine deaminase, and adenosine receptors mediate costimulatory signals in the immunological synapse. Proc Natl Acad Sci USA 2005; 102:9583-8.
33. Bracke KR, Demedts IK, Joos GF, Brusselle GG. CC-chemokine receptors in chronic obstructive pulmonary disease. Inflamm Allergy Drug Targets 2007; 6:75-9.
34. Somborac-Ba ura A, Buljevi S, Rumora L, et al. Decreased soluble dipeptidyl peptidase IV activity as a potential serum biomarker for COPD. Clin Biochem 2012; 45:1245-50.
35. Chang XY, Yang Y, Jia XQ, et al. Expression and clinical significance of serum dipeptidyl peptidase IV chronic obstructive pulmonary disease. Am J Med Sci 2016; 351:244-52.
36. Memish ZA, Al-Tawfiq JA, Makhdoom HQ, et al. Screening for Middle East respiratory syndrome coronavirus infection in hospital patients and their healthcare worker and family contacts: A prospective descriptive study. Clin Microbiol Infect 2014; 20:469-74.
37. Decramer M, Janssens W, Miravitlles M. Chronic obstructive pulmonary disease. Lancet 2012; 379:1341-51.